Thr378
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.4
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Thr378  -  MOR-1 (human)

Site Information
NtRDHPstANtVDRT   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 20727901

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 2 ) , mass spectrometry ( 2 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
neuroblastoma ( 2 )
Relevant cell line - cell type - tissue:

Upstream Regulation
Treatments:
1DMe ( 2 ) , AT-034 ( 1 ) , AT-121 ( 1 ) , AT-201 ( 1 ) , AT-324 ( 1 ) , cebranopadol ( 1 ) , DAMGO ( 2 )

References 

1

Dasgupta P, et al. (2022) Attenuated G protein signaling and minimal receptor phosphorylation as a biochemical signature of low side-effect opioid analgesics. Sci Rep 12, 7154
35504962   Curated Info

2

Moul├ędous L, et al. (2012) GRK2 protein-mediated transphosphorylation contributes to loss of function of ╬╝-opioid receptors induced by neuropeptide FF (NPFF2) receptors. J Biol Chem 287, 12736-49
22375000   Curated Info